Joseph Kost,Riki Goldbart,Tamar Traitel,Nitzan Marelly,Assaf Rudich,Etili Hollander
申请号：
US15241293
公开号：
US10350235B2
申请日:
2016.08.19
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides a complex comprising at least one phosphoinositide and at least one positively charged modified polysaccharide, pharmaceutical compositions comprising the complex, methods for treatment of a disease, disorder or condition associated with impaired phosphoinositide-mediated signaling comprising administering the complex to an subject in need, and methods for delivery of a phosphoinositide into cells, comprising contacting the cells with the complex of the invention.
